Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia

International Psychogeriatrics

Volumn 17, Issue 4, 2005, Pages 591-604

  Duran J C ^a   Greenspan, A ^b   Diago, J I ^c   Gallego, R ^c   Martinez, G ^c  

^a H Juan Grande   (Spain)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Janssen Cilag SA   (Spain)

Author keywords

Atypical antipsychotic; BPSD; Sleep wake cycle

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HALOPERIDOL; HYPNOTIC AGENT; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; RISPERIDONE; SEDATIVE AGENT; THIORIDAZINE;

AGED; AGITATION; ANXIETY DISORDER; AROUSAL; ARTICLE; ASTHENIA; BEHAVIOR; BEHAVIOR DISORDER; CAREGIVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HEADACHE; HUMAN; HYPERSALIVATION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; NIGHT; PARESTHESIA; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; VISUAL DISORDER; WAKEFULNESS;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DEMENTIA; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISPERIDONE; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 28744435663     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S104161020500219X     Document Type: Article

References (39)

1. Arriola, E. and Diago, J. I. (2002). Treatment with risperidone: positive impact on patients with BPSD and caregiver stress. Journal of Clinical Psychiatry, 63, 1056.
2. Brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychotic agitation of dementia. Journal of Clinical Psychiatry, 64, 134-143.
3. Chan, W. C., Lam, L. C. W., Choy, C. N. P., Leung, V. P. Y., Li, S. W. and Chiu, H. F. K. (2001). A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioral and psychological symptoms in Chinese dementia patients. International Journal of Geriatric Psychiatry, 16, 1156-1162.
4. Chenier, M. C. (1997). Review and analysis of caregiver burden and nursing home placement. Geriatric Nursing, 18, 121-126.
5. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatrie Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.
6. De Deyn, P. P. et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 53, 946-955.
7. Dursun, S. M., Patel, J. K., Burke, J. G. and Reveley, M. A. (1999). Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. Journal of Psychiatry and Neuroscience, 24, 333-337.
8. Feldman, P. D. et al. (2004). Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. Journal of the American Medical Directors' Association, 5, 38-46.
9. Finkel, S. (2000). Introduction to behavioral and psychological symptoms of dementia (BPSD). International Journal of Geriatric Psychiatry, 15 Suppl 1, S2-S4.
10. Finkel, S. I. et al. (1996). Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics, 8, 497-500.
11. Fuller, G. F. (2000). Falls in the elderly. American Family Physician, 61, 2159-2168, 2173-2174.
12. Gill, S. S. et al. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. British Medical Journal, 330, 445-448.
13. Goldberg, R. J. and Goldberg, J. (1997). Risperidone for dementia-related disturbed behaviour in nursing home residents: a clinical experience. International Psychogeriatrics, 9, 65-68.
14. Hachinski, V. C. et al. (1975). Cerebral blood flow in dementia. Archives of Neurology, 32, 632-637.
15. Haffmans, P. M. J., Oolders, J. M., Hoencamp, E. and Arenas, J. B. A. M. (2002). The effects of risperidone versus haloperidol on sleep patterns of schizophrenic patients. A double-blind, randomized pilot study. Presented at the 11th Congress of the Association of European Psychiatrists, Stockholm, Sweden, 4-8 May 2002. European Psychiatry 2002, 17 (Suppl 2), 241-292.
16. Herrmann, N. (2001). Recommendations for the management of behavioral and psychological symptoms of dementia. Canadian Journal of Neurological Science, 28 Suppl 1, S96-S107.
17. Herrmann, N., Mamdani, M. and Lanctôt, K. L. (2004). Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry, 161, 1113-1115.
18. Herrmann, N. and Lanctôt, K. (2005). Do atypical antipsychotics cause stroke? CNS Drugs, 19, 91-103.
19. Katz, I. R. et al. (1999). Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. Journal of Clinical Psychiatry, 60, 107-115.
20. Katz, I. R., Schneider, L., Kozma, C. and Rupnow, M. F. T. (2004). Risk of falls in dementia patients: analysis of a randomized, double-blind risperidone trial. International Journal of Geriatric Psychiatry, 12, 499-508.
21. Kiely, D. K., Kiel, D. P., Burrows, A. B. and Lipsitz, L. A. (1998). Identifying nursing home residents at risk for falling. Journal of the American Geriatrics Society, 46, 551-555.
22. Klein, D. A. et al. (1999). Wandering behavior in community-residing persons with dementia. International Journal of Geriatric Psychiatry, 14, 272-279.
23. Lingjaerde, O., Ahlfors, U. G., Bech, P., Dencker, S. J. and Elgen, K. (1987) The UKU side-effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica. Supplementum, 334, 1-100.
24. Marx, M. S., Cohen-Mansfield, J. and Werner, P. (1990). Agitation and falls in institutionalized elderly persons. Journal of Applied Gerontology, 9, 106-117.
25. Mion, L. C., Gregor, S., Buettner, M., Chwirchak, D., Lee, O. and Paras, W. (1989). Falls in the rehabilitation setting: incidence and characteristics. Rehabilitation Nursing, 14, 17-22.
26. Myers, A. H., Baker, S. P., Van Natta, M. L., Abbey, H. and Robinson, E. G. (1991). Risk factors associated with falls and injuries among elderly institutionalized persons. American Journal of Epidemiology, 133, 1179-1190.
27. Royuela, A. and Macías, J. A. (1997). Effects of risperidone and other antipsychotic agents on sleep quality. European Neuropsychopharmacology, 7 (Suppl 2), p S210.
28. Schreiner, A. (2002). Sleep quality in schizophrenic patients and the effects of antipsychotic medication. Presented at the 11th Congress of the Association of European Psychiatrists, Stockholm, Sweden, 4-8 May 2002. European Psychiatry, 17 (Suppl 2), 241-292.
29. Schwalen, S. and Kurz, A. (2002). Risperidone for the treatment of behavioral disorders in dementia. Nervenheilkunde, 21, 208-213.
30. Shaw, F. E. et al. (2003). Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomized controlled trial. British Medical Journal, 326, 73-78.
31. Spanish Summary of Product Characteristics available at http://www.agemed.es/documentos/notasPrensa/csmh/2004/pdf/risperidona_1t.pdf
32. Steele, C., Rovner, B., Chase, G. A. and Folstein, M. (1990). Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. American Journal of Psychiatry, 147, 1049-1051.
33. Swearer, J. M. (1994). Behavioral disturbances in dementia. In J. C. Morris (Ed.) Handbook of Dementing Illnesses (pp. 499-527). New York: Marcel Dekker.
34. Vitiello, M. V. and Borson, S. (2001). Sleep disturbance in patients with Alzheimer's disease. CNS Drugs, 15, 777-796.
35. Vitiello, M. V., Prinz, P. N., Williams, D. E., Frommlet, M. S. and Ries, R. K. (1990). Sleep disturbances in patients with mild-stage Alzheimer's disease. Journal of Gerontology, 45, M131-M138.
36. Wancata, J. (2002). Risperidone improves behavioral and psychological symptoms of dementia in 975 elderly patients: results of a 6 weeks survey in Austria. International Journal of Neuropsychopharmacology, 5 Suppl 1, S90.
37. Wooltorton, E. (2002). Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Canadian Medical Association Journal, 167, 1269-1270.
38. Wooltorton, E. (2004). Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials. Canadian Medical Association Journal, 170, 1395.
39. Yamashita, H., Morinobu, S., Yamawaki, S., Horiguchi, J. and Nagao, M. (2002). Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Research, 109, 137-142.